Visit us at Sierra Spine March 7-9th, in Mammoth Lakes, CA where Mathias Daniels, MD will present “Evaluating Osteobiologics for High-Risk Patients”. Visit our booth to learn more about i-FACTOR which is powered by P-15 Osteogenic Cell Binding Peptide and backed by level 1 human clinical data. Click to download the presentation invite. https://hubs.ly/Q039bV5C0
Cerapedics Inc.
生物技术研究
Westminster，CO 9,010 位关注者
Cerapedics is an Orthopedics company aspiring to redefine the standard of care for bone repair.
关于我们
Cerapedics is a global, commercial-stage orthopedics company that aspires to redefine the standard of care for bone repair by healing bones faster and at higher rates, without compromising safety, so that patients can live their healthiest lives. Bone grafts, including Cerapedics’ products, are used in over four million annual spine, orthopedics, trauma and interventional procedures world-wide. Cerapedics’ product, i-FACTOR?, is FDA approved for single-level cervical spinal fusions in the United States. Cerapedics’ next-generation product is currently being evaluated for use in lumbar interbody fusion through ASPIRE, a pivotal IDE study, and has been granted a Breakthrough Device Designation by the FDA. Cerapedics is headquartered in Westminster, CO.
- 网站
-
https://www.cerapedics.com
Cerapedics Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Westminster，CO
- 类型
- 私人持股
- 创立
- 2001
- 领域
- Bone Grafts、iFactor、Orthopedics、Bone Graft Substitutes、Spine、Spine Surgery和Osteobiologic
地点
-
主要
获取路线
11025 Dover Street
Suite 1600
US，CO，Westminster，80021
Cerapedics Inc.员工
动态
-
It was great to connect with colleagues at Canadian Spine Society. ? Did you attend? What was your biggest takeaway? Drop it in the comments ?? ? #Cerapedics #iFACTOR #P15PeptidePower #SEEtheDifference #RepairingBonesHealingLives
-
-
It was great to connect with colleagues at Spine Summit and hear Peter Passias, MD, Arjun Sebastian, MD and Alp Ozpinar, MD discuss the latest on Optimizing Clinical Outcomes in High-Risk Patients: An Evidence-Based Approach for the Selection of Bone Grafts. Did you attend? What was your biggest takeaway? Drop it in the comments ?? ? #Cerapedics #iFACTOR #P15PeptidePower #SEEtheDifference #RepairingBonesHealingLives
-
-
Visit us at the Annual Scientific Conference of the Canadian Spine Society on February 25-28 in Quebec, Canada. Meet with our team to learn more about i-FACTOR Peptide-Enhanced Bone Graft, powered by P-15 Osteogenic Cell Binding Peptide and backed by Level 1 human clinical data. Learn More https://hubs.ly/Q037Nq2Y0
-
-
Visit us at Spine Summit February 20-23rd, in Tampa, FL where Boyle Cheng, PhD will present “Immunomodulation By P-15”. Visit our booth to learn more about i-FACTOR which is powered by P-15 Osteogenic Cell Binding Peptide and backed by level 1 human clinical data. Click to download the presentation invite. https://hubs.ly/Q037hf5T0
-
-
Visit us at Spine Summit February 20-23rd, in Tampa, FL where Peter Passias, MD, Arjun Sebastian, MD and Alp Ozpinar, MD will present “Optimizing Clinical Outcomes in High-Risk Patients: An Evidence-Based Approach for the Selection of Bone Grafts”. Visit our booth to learn more about i-FACTOR, which is powered by P-15 Osteogenic Cell Binding Peptide and backed by level 1 human clinical data. Click to download the presentation invite. https://hubs.ly/Q0371M_10
-
-
See how spine experts weigh the evidence and outcomes for bone grafts in their high-risk patients in spinal fusion surgery. #Elevatingbonegraftselection Expert Faculty: Safdar N. Khan, MD, FAOA, FAAOS, John O'Toole, and Dr. Michael Steinmetz will be sharing their expertise. #SpineCare #MedicalEducation #CME #BoneGrafting #Cerapedics #HealthcareInnovation #Elevatingbonegraftselection
Hear from experts Drs. Safdar N. Khan, John O'Toole, and Michael Steinmetz as they delve into the evidence and outcomes of bone grafting options for high-risk patients! Watch this 3-part series and earn complimentary CME credit! ??The Complex Landscape for Bone Grafting ?? Watch now: https://bit.ly/4gae19D ?? High-Risk Patients: Making the Right Biologic Choices ?? Watch now: https://bit.ly/3ARVVJm ?? Fusion Assessment in the Spine Practice: Clinical Assessment and Practical Realities ?? Watch now: https://bit.ly/3TrUxUf
-
-
Visit us at NASS Evidence & Technology February 12-15th, in Lake Tahoe, CA where Katie Lakstins, PhD will present “Evaluating Osteobiologics for High-Risk Patients”. Visit our booth to learn more about i-FACTOR which is powered by P-15 Osteogenic Cell Binding Peptide and backed by level 1 human clinical data. Click to download the presentation invite. https://hubs.ly/Q035SpRL0
-
-
Visit us at Southern Neurosurgical Society February 5-8th, in Marco Island, FL where Cerapedics will present “Evaluating Osteobiologics for High-Risk Patients”. Visit our booth to learn more about i-FACTOR which is powered by P-15 Osteogenic Cell Binding Peptide and backed by level 1 human clinical data. Click to download the presentation invite https://hubs.ly/Q034Vcxq0
-
-
It was great to connect with colleagues at Selby Spine and hear Jeff Marx, PhD discuss the latest on Evaluating Osteobiologics for High-Risk Patients. Did you attend? What was your biggest takeaway? Drop it in the comments ?? #Cerapedics #iFACTOR #P15PeptidePower #SEEtheDifference #RepairingBonesHealingLives
-